| Systematic (IUPAC) name | |
|---|---|
| Diammine[(hydroxy-κO)acetato(2-)-κO]platinum | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| CAS number | 95734-82-0 |
| ATC code | None |
| PubChem | CID 6917890 |
| UNII | 8UQ3W6JXAN |
| KEGG | D01416 |
| Chemical data | |
| Formula | C2H8N2O3Pt |
| Mol. mass | 303.17 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum compound which is used for cancer chemotherapy.[1] It produces less nausea, vomiting and nephrotoxicity than other platinum-containing drugs.[2]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)